looking forward to ash 2021: key updates in multiple myeloma
Published 2 years ago • 219 plays • Length 1:03Download video MP4
Download video MP3
Similar videos
-
3:48
looking forward to ash 2021: key updates in dlbcl
-
1:43
ash 2022: what to look forward to in the field of multiple myeloma
-
4:41
key takeaways from ash 2020 in multiple myeloma
-
1:01
car-t: myeloma toxicities
-
4:27
antibody-based targeting of bcma in multiple myeloma
-
4:40
all at ash: four key updates
-
2:19
aml: what to look forward to at ash 2020
-
3:11
epigenetics and myeloma
-
34:36
healthcare direkt v.43: dnb-analytikerns köptips och immunicums vd om sin uppdaterade strategi
-
1:19:53
tin fonder investerarträff 2020
-
1:30
ash 2022 - the role of mass spectrometry in managing patients with monoclonal gammopathies
-
3:35
supporting future generations of female hematologists
-
1:24
highlights from the 2016 european multiple myeloma academy (emma) and overview of emma 2017
-
1:38
what to look forward to at ash | ola landgren, md, phd | ash 2022
-
3:37
smoldering myeloma: state of the art
-
3:56
iv daratumumab in r/r myeloma: bodyweight analysis
-
4:45
horizon: melflufen & dexamethasone in myeloma
-
1:29
nina shah: highlights from eha
-
4:30
horizon: melflufen dexamethasone in r/r myeloma
-
1:39:53
advance in multiple myeloma an update from ash
-
57:32
latest myeloma research updates from the ash 2019 meeting